Anterolateral Bowing | NF1 Association | Recalcitrant Nonunion
CRAWFORD CLASSIFICATION
Critical Must-Knows
- NF1 mutation drives impaired osteoblast function and poor bone healing
- Anterolateral bowing begins in infancy and fractures early leading to pseudarthrosis
- Crawford classification guides prognosis and timing of intervention
- Union rates remain low despite modern techniques; refracture is common
- Cross-union technique and vascularised fibula offer highest long-term success
Clinical Pearls
- "Always screen for NF1 stigmata in any anterolateral bow
- "Type IV pseudarthrosis has the worst healing potential
- "Ilizarov with compression-distraction remains gold standard in many centres
- "Amputation rate still 10-30 percent in refractory cases worldwide
Clinical Imaging
Radiographic Progression of Anterolateral Bowing to Pseudarthrosis
Congenital pseudarthrosis of the tibia (CPT) is defined by a dysplastic nonunion that develops after pathologic fracture through an area of anterolateral bowing. The natural history begins with a sclerotic or cystic lesion in the distal third of the tibia that progresses to fracture and established pseudarthrosis. Early radiographs show anterolateral bowing without fracture; later films demonstrate atrophic bone ends, sclerosis, and eventual pseudarthrosis with fibular involvement in over 50 percent of cases.
Critical Congenital Pseudarthrosis Exam Points
NF1 Association
50-80 percent of CPT cases have NF1. Look for cafe-au-lait macules, axillary freckling, Lisch nodules, and family history. NF1 drives the poor bone biology and higher refracture risk.
Anterolateral Bowing
The hallmark deformity. Begins in infancy, apex at junction of middle and distal thirds. Progresses to fracture by age 2-3 years in most untreated cases. Differentiate from posteromedial bowing which has excellent prognosis.
Crawford Classification
Guides prognosis and treatment timing. Type I has best prognosis; Type IV established pseudarthrosis has poorest healing potential. Serial radiographs track progression from bowing to cystic change to frank nonunion.
Recalcitrant Nature
Union is difficult to achieve and maintain. Even after apparent radiographic union, refracture rates exceed 50 percent. Multiple surgeries common; amputation remains a realistic endpoint in 10-30 percent of severe cases.
Quick Decision Guide
| Presentation | Diagnosis | Treatment | Key Pearl |
|---|---|---|---|
| Infantile anterolateral bow, no fracture | Crawford I-II on X-ray, NF1 screen positive | Prophylactic bracing, serial observation | Prevent fracture before pseudarthrosis develops |
| Cystic lesion or impending fracture | Crawford III, narrow canal with sclerosis | Consider early surgery or protected weight-bearing | Pre-pseudarthrosis window for intervention |
| Established pseudarthrosis, mobile nonunion | Crawford IV, atrophic bone ends | Surgical reconstruction (Ilizarov, vascular fibula, cross-union) | High refracture risk; counsel family early |
BSCPCrawford Classification Progression
| B | Bowing alone Type I normal canal, best prognosis |
| S | Sclerotic narrowing Type II canal sclerosis, early protection |
| C | Cystic pre-fracture Type III cystic lesion, consider surgery |
| P | Pseudarthrosis Type IV established nonunion, worst outcome |
| B | Bowing alone Type I normal canal, best prognosis | C | Cystic pre-fracture Type III cystic lesion, consider surgery |
| S | Sclerotic narrowing Type II canal sclerosis, early protection | P | Pseudarthrosis Type IV established nonunion, worst outcome |
Hook:BSCP takes the tibia from bowing to pseudarthrosis - catch it before P!
CALMSNF1 Features in CPT
| C | Cafe-au-lait spots greater than 5 mm in children, greater than 15 mm in adults |
| A | Axillary freckling Crowe sign, highly specific for NF1 |
| L | Lisch nodules Iris hamartomas on slit-lamp exam |
| M | Macrocephaly Common in NF1, check head circumference |
| S | Skeletal dysplasia Tibial pseudarthrosis, scoliosis, sphenoid dysplasia |
| C | Cafe-au-lait spots greater than 5 mm in children, greater than 15 mm in adults | M | Macrocephaly Common in NF1, check head circumference |
| A | Axillary freckling Crowe sign, highly specific for NF1 | S | Skeletal dysplasia Tibial pseudarthrosis, scoliosis, sphenoid dysplasia |
| L | Lisch nodules Iris hamartomas on slit-lamp exam |
Hook:CALMS reminds you to screen every CPT patient for NF1 stigmata!
RIBVCSurgical Options for Established CPT
| R | Rod fixation Intramedullary Williams or telescoping rod plus graft |
| I | Ilizarov method Compression-distraction, bone transport, high union rate |
| B | BMP augmentation Off-label use to enhance biology in atrophic nonunion |
| V | Vascularised fibula Microsurgical transfer, excellent for large defects |
| C | Cross-union Tibia-fibula synostosis technique, lowest refracture |
| R | Rod fixation Intramedullary Williams or telescoping rod plus graft | V | Vascularised fibula Microsurgical transfer, excellent for large defects |
| I | Ilizarov method Compression-distraction, bone transport, high union rate | C | Cross-union Tibia-fibula synostosis technique, lowest refracture |
| B | BMP augmentation Off-label use to enhance biology in atrophic nonunion |
Hook:RIBVC - five letters, five strategies for the toughest nonunion in orthopaedics!
Overview and Epidemiology
Why This Matters
Congenital pseudarthrosis of the tibia is one of the most challenging conditions in paediatric orthopaedics. Despite advances in fixation, biology, and microsurgery, union rates remain 50-80 percent at best and refracture occurs in over half of united cases. Early recognition of anterolateral bowing before fracture, NF1 screening, and realistic family counselling are essential. The condition accounts for a disproportionate share of paediatric amputation and multiple surgical interventions worldwide.
Epidemiology
- Incidence: 1 in 140,000 to 1 in 250,000 live births
- NF1 association: 50-80 percent of all CPT cases
- Sex ratio: Slight male predominance (1.2:1)
- Laterality: Unilateral in greater than 95 percent; right equals left
- Age at fracture: Mean 2.5 years, range birth to 12 years
Clinical Impact
- Recalcitrant nonunion: Highest failure rate of any long-bone nonunion
- Refracture: greater than 50 percent after apparent union
- Limb-length discrepancy: 2-5 cm common at skeletal maturity
- Amputation rate: 10-30 percent in refractory cases
- Multiple surgeries: Average 3-6 procedures per patient
Pathophysiology
Biology of NF1-Related CPT
NF1 is caused by loss-of-function mutations in the neurofibromin gene on chromosome 17. Neurofibromin normally inhibits RAS signalling; its absence leads to uncontrolled RAS activity, impaired osteoblast differentiation, increased osteoclast activity, and a fibrous hamartoma replacing normal bone at the pseudarthrosis site. The hamartoma produces excessive TGF-beta and has poor vascularity, explaining the atrophic nonunion and high refracture rate even after stable fixation. Fibular pseudarthrosis coexists in 50-75 percent of cases and must be addressed to prevent valgus collapse.
Pathologic Cascade from Bowing to Pseudarthrosis
| Stage | Pathology | Radiograph | Risk if Untreated |
|---|---|---|---|
| Infantile bowing | Periosteal dysplasia, NF1 hamartoma | Anterolateral bow, normal canal (Crawford I) | Fracture by age 3 years in 70 percent |
| Cystic degeneration | Medullary narrowing, sclerosis | Type II-III changes, impending fracture | Pathologic fracture within months |
| Established pseudarthrosis | Atrophic bone ends, fibrous hamartoma | Type IV mobile nonunion +/- fibula | Refracture, shortening, deformity |
Why Healing Fails
Poor biology: Deficient osteoprogenitor cells, excessive fibrous tissue, low BMP responsiveness. Mechanical factors: Narrow distal fragment, poor purchase for fixation, high shear at apex. Vascular compromise: Hamartoma is hypovascular; periosteal stripping during surgery worsens it. Fibular involvement: Untreated fibular pseudarthrosis leads to valgus and refracture.
Why Anterolateral Bowing
Growth disturbance: Asymmetric physeal growth from NF1 dysplasia. Periosteal tethering: Fibrous hamartoma tethers lateral cortex. Muscle imbalance: Weak anterior compartment contributes to apex anterior deformity. Mechanical axis: Lateral bow places distal tibia in varus, increasing fracture risk.
Classification and Types
Crawford Classification (1986) - Gold Standard
| Type | Radiographic Features | Prognosis | Treatment Approach |
|---|---|---|---|
| Type I | Anterolateral bow, normal medullary canal | Best; may never fracture | Observation, prophylactic bracing |
| Type II | Narrowed canal, cortical sclerosis | Good if protected | Bracing, early surgery if cystic change |
| Type III | Cystic lesion at apex | Moderate; high fracture risk | Consider prophylactic surgery |
| Type IV | Established pseudarthrosis +/- fibula | Poorest; high refracture | Surgical reconstruction mandatory |
Crawford classification remains the most widely used because it directly correlates with natural history and guides the timing of surgical intervention.
Clinical Assessment
History
- Onset: Noticed bowing in first year of life
- Family history: NF1 in first-degree relatives
- Previous fractures: Number, age, healing attempts
- Functional limitation: Pain, limp, shoe wear problems
- Prior surgery: Number of procedures, complications
Examination
- Inspection: Anterolateral bow, skin dimpling, cafe-au-lait spots
- Palpation: Mobile pseudarthrosis, warmth, tenderness
- Gait: Short limb, circumduction, valgus thrust
- Neurovascular: Usually intact; check for NF1 neuropathy
- Associated: Scoliosis screen, limb-length discrepancy
Differentiating True CPT from Other Bowing
Posteromedial bowing: Benign, resolves spontaneously, excellent prognosis, no NF1 link. Physiologic bowing: Symmetric, physiologic varus, resolves by age 2. Rickets / metabolic: Bilateral, metaphyseal changes, biochemical abnormalities. Osteogenesis imperfecta: Multiple fractures, blue sclerae, family history, collagen mutation. Always obtain full-length standing radiographs and NF1 clinical screen on every anterolateral bow.
Differential Diagnosis of Tibial Bowing in Infancy
| Condition | Direction | NF1 Link | Prognosis | Key Discriminator |
|---|---|---|---|---|
| Congenital pseudarthrosis | Anterolateral | 50-80 percent | Poor without surgery | Crawford changes, mobile nonunion |
| Posteromedial bowing | Posteromedial | None | Excellent, resolves | Spontaneous correction, calcaneovalgus foot |
| Physiologic varus | Symmetric varus | None | Resolves by age 2 | No apex, normal bone quality |
| Osteogenesis imperfecta | Variable | Rare | Variable with bisphosphonates | Multiple fractures, blue sclerae |
Don't Miss NF1 in Every CPT Patient
NF1 stigmata checklist: greater than 6 cafe-au-lait macules greater than 5 mm (prepubertal), axillary/inguinal freckling, greater than 2 neurofibromas or 1 plexiform, optic glioma, greater than 2 Lisch nodules, sphenoid dysplasia or thinning long bone, first-degree relative with NF1. Two or more criteria confirm NF1. Genetic testing confirms but is not required for diagnosis.
Investigations
Imaging and Laboratory Protocol
Views: AP and lateral tibia/fibula, full-length standing both legs, hand for bone age if discrepancy. Look for: Crawford type, fibular status, shortening, ankle valgus, proximal migration of fibula. Clinical correlation: Serial films every 3-6 months in bowing stage to detect cystic change or fracture.
Indication: Characterise pseudarthrosis morphology, bone stock, and plan fixation or transport. Findings: Atrophic bone ends, medullary canal diameter, hamartoma extent, fibular pseudarthrosis. Pre-op planning: Determine rod diameter, Ilizarov ring size, need for bone transport segment length.
Indication: Pre-operative planning for vascularised fibula or cross-union; assess hamartoma extent. Findings: Fibrous hamartoma replacing bone, periosteal reaction, muscle quality, vascular anatomy. Utility: Helps decide between Ilizarov, vascular fibula, or combined approaches.
NF1 testing: Clinical diagnosis sufficient; genetic confirmation if family planning or atypical features. Bloods: Full blood count, coagulation, type and screen before major reconstruction. Bone biochemistry: Calcium, phosphate, PTH, vitamin D to exclude metabolic contributors.
Imaging Pearl
X-rays are the cornerstone; diagnosis and classification are radiographic. MRI and CT are adjuncts for surgical planning only. Do not delay bracing or referral while awaiting advanced imaging in an infant with anterolateral bowing.
Management Algorithm
Pre-fracture Anterolateral Bowing (Crawford I-III)
Goal: Prevent fracture and pseudarthrosis development through protected weight-bearing and monitoring.
Management Protocol
Bracing: Custom total-contact KAFO or AFO with anterior shell to counteract bow. Weight-bearing: As tolerated; encourage normal development. Surveillance: Clinical and radiographic review every 3 months. Family education: Signs of fracture (pain, swelling, refusal to bear weight).
Decision point: Prophylactic surgery versus continued bracing. Factors favouring surgery: Rapid cystic expansion, narrow canal less than 50 percent normal, family compliance concerns. Surgical options: Intramedullary rod insertion before fracture, or Ilizarov with prophylactic compression. Counsel: Even with surgery, fracture risk remains elevated.
Bracing Pearl
The goal of bracing is to convert a high-risk Crawford II or III tibia into a Type I that never fractures. Success depends on compliance and early application before the first fracture. Once fracture occurs, the biology changes permanently and union becomes far more difficult.
Complications
| Complication | Incidence | Risk Factors | Management |
|---|---|---|---|
| Refracture after union | greater than 50 percent overall | NF1, narrow canal, early weight-bearing | Re-frame or revise fixation; consider cross-union |
| Limb-length discrepancy | 2-5 cm common at maturity | Multiple surgeries, growth disturbance | Epiphysiodesis, lengthening, shoe lift |
| Ankle valgus / instability | 30-50 percent with fibular involvement | Untreated fibular pseudarthrosis | Fibular stabilisation or supramalleolar osteotomy |
| Nonunion / persistent pseudarthrosis | 10-30 percent after surgery | Atrophic biology, inadequate fixation | Revision surgery, vascular fibula, cross-union |
| Amputation | 10-30 percent refractory cases | Multiple failed surgeries, infection, family choice | Below-knee amputation with modern prosthetics |
Prevention of Refracture is the Real Challenge
Achieving radiographic union is only the first battle. The second, and often harder, battle is maintaining union through skeletal maturity. Protect the leg with bracing or frame for 6-12 months after apparent union. Monitor closely for early refracture. Cross-union and vascularised fibula currently offer the lowest refracture rates in published series.
Outcomes and Prognosis
Outcomes by Surgical Strategy
| Technique | Union Rate | Refracture Rate | Limb Salvage |
|---|---|---|---|
| Ilizarov alone | 70-85 percent | 40-60 percent | 70-85 percent |
| Vascularised fibula | 80-95 percent | 20-40 percent | 85-95 percent |
| Cross-union technique | greater than 90 percent | less than 20 percent | greater than 95 percent |
| IM rod + graft | 50-70 percent | greater than 60 percent | 60-75 percent |
Prognostic Factors
Best prognosis: Crawford I-II caught before fracture, non-NF1, good family compliance, access to specialist paediatric limb reconstruction centre. Poor prognosis: NF1 positive, Crawford IV at presentation, fibular pseudarthrosis, prior failed surgery, short distal fragment, infection. Key threshold: First fracture before age 3 years predicts worse outcome; multiple surgeries before age 5 years increase amputation risk.
Evidence Base and Key Trials
Osseous manifestations of neurofibromatosis in childhood
- Original description of the four-type radiographic classification still used worldwide
- Type I had best prognosis; Type IV established pseudarthrosis had poorest healing
- NF1 present in 55 percent of the cohort; associated with worse outcome
- Multiple surgical attempts common; amputation rate 18 percent
Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1
- NF1 mutation identified in 75 percent of CPT patients in a large registry cohort
- NF1-CPT patients had higher refracture rate and more surgical procedures than non-NF1
- Somatic second-hit mutations in the pseudarthrosis tissue support two-hit hypothesis
- Clinical NF1 criteria sufficient for diagnosis; genetic testing not mandatory
Treatment of congenital pseudoarthrosis of the tibia using the Ilizarov technique
- Ilizarov compression-distraction achieved union in 85 percent of 15 CPT cases
- Fibular stabilisation or cross-union reduced valgus deformity and refracture
- Bone transport used for large defects; average treatment time 12 months
- Refracture occurred in 40 percent; longer frame time improved durability
Congenital pseudarthrosis of the tibia: long-term followup of 29 cases treated by microvascular bone transfer
- Vascularised contralateral fibula achieved union in 92 percent of 25 cases
- Hypertrophy of the graft occurred in 80 percent allowing full weight-bearing
- Donor ankle instability managed with syndesmotic screw or distal tibiofibular fusion
- Refracture rate 28 percent; lower than IM rod series of the era
Exam Viva Scenarios
Use these scenarios to practise clinical reasoning and management decisions
Scenario 1: Infant with Anterolateral Bowing
"A 14-month-old presents with progressive anterolateral bowing of the right tibia noticed since age 6 months. The child has six cafe-au-lait macules greater than 5 mm and axillary freckling. X-rays show Crawford Type II changes with cortical sclerosis and narrowed medullary canal. No fracture has occurred. What is your diagnosis, work-up, and management plan?"
Scenario 2: Refractory Pseudarthrosis after Multiple Surgeries
"A 7-year-old with known NF1 and Crawford Type IV congenital pseudarthrosis has undergone three failed attempts at union (two IM rod plus graft, one Ilizarov). The leg is 4 cm short, the pseudarthrosis is mobile with atrophic bone ends, and the fibula is also pseudarthrotic with ankle valgus. The family is desperate to avoid amputation. What surgical strategy would you recommend?"
MCQ Practice Points
Classification Question
Q: Which Crawford type has the worst prognosis for union? A: Type IV (established pseudarthrosis). Type I has normal canal and best prognosis; Type IV has atrophic bone ends, fibrous hamartoma, and the highest refracture rate despite surgery.
NF1 Association Question
Q: What percentage of congenital pseudarthrosis of the tibia cases are associated with NF1? A: 50-80 percent. Every child with CPT requires full NF1 clinical screening (cafe-au-lait count, axillary freckling, Lisch nodules, family history). NF1-positive cases have worse biology and higher refracture risk.
Natural History Question
Q: What is the typical age of first fracture in untreated anterolateral bowing? A: Mean 2.5 years (range birth to 12 years). Most untreated Crawford II-III cases fracture by age 3 years. Once fracture occurs, the pseudarthrosis biology is established and healing potential drops dramatically.
Treatment Question
Q: Which surgical technique currently reports the lowest refracture rate in refractory CPT? A: Cross-union (tibia-fibula synostosis). Recent series show union greater than 90 percent and refracture less than 20 percent by creating a single-bone leg with larger cross-sectional area and better mechanics.
Prognosis Question
Q: What is the overall amputation rate in congenital pseudarthrosis of the tibia? A: 10-30 percent in refractory cases. Despite modern techniques, a subset of patients with multiple failures, infection, or severe shortening ultimately undergo below-knee amputation with excellent prosthetic function.
Guidelines, Registries & Global Practice
Global Epidemiology
- Incidence 1 in 140,000-250,000 worldwide; no clear geographic variation
- NF1 association consistent across populations (50-80 percent)
- Amputation rates higher in low-resource settings due to limited access to Ilizarov and microsurgery
- Specialist centres in high-resource countries report better limb salvage (greater than 85 percent)
Practice Variation by Resource Setting
- High-resource: Ilizarov, vascular fibula, cross-union, BMP, dedicated limb reconstruction teams
- Limited-resource: IM rod plus autograft, prolonged bracing, higher amputation threshold
- Universal principle: Early bracing before fracture and realistic family counselling are low-cost interventions that improve outcome everywhere
- Surgery: Concentrated in 10-15 global centres with sufficient case volume for expertise
Society and Reference Guidance (Side by Side)
| Source | Diagnosis emphasis | Surgical strategy | Long-term protection |
|---|---|---|---|
| POSNA / IPOS (paediatric societies) | Crawford classification + NF1 screen on every anterolateral bow | Ilizarov or vascular fibula at specialist centres; cross-union for salvage | 12 months protected weight-bearing after union; monitor to skeletal maturity |
| EPOS / European paediatric groups | Early referral to limb reconstruction units before first fracture | Fibular stabilisation mandatory; cross-union gaining favour | Long-term bracing until growth complete |
| AAOS / US centres | Genetic counselling offered for NF1-positive families | Individualised; IM rod, Ilizarov, or vascular fibula per surgeon preference | Refracture risk discussed; amputation offered after multiple failures |
Registry and Evidence Note
There is no international CPT registry. Evidence is derived from single-centre series and expert consensus. The European Paediatric Orthopaedic Society (EPOS) and POSNA have published treatment algorithms emphasising early referral, fibular management, and prolonged protection. Cross-union is the most recent advance with the lowest published refracture rates.
Documentation Essentials (Globally Applicable)
Record in every anterolateral bowing case:
- Crawford type on initial and serial radiographs
- NF1 clinical criteria met or excluded
- Bracing compliance and family education provided
- Referral to specialist centre documented A missed opportunity to brace before fracture is a recurring source of preventable morbidity worldwide. Always document the bowing direction, NF1 screen, and management plan at the first visit.
Controversies & Areas of Uncertainty
Prophylactic surgery versus bracing in Crawford III
Some centres advocate early rod insertion or Ilizarov compression before fracture in cystic lesions; others continue bracing until fracture occurs. No randomised data exist; decision is individualised by family compliance, canal diameter, and centre expertise.
Role of BMP in CPT
Off-label BMP-2 or 7 is used by some surgeons to augment biology at the pseudarthrosis site. Small series suggest modest improvement in union rates, but concerns remain about cost, heterotopic ossification, and lack of high-level evidence.
Best first-line surgery for Crawford IV
Ilizarov, vascularised fibula, and cross-union all have advocates. No head-to-head trials. Ilizarov is most accessible globally; vascular fibula requires microsurgery; cross-union is emerging as preferred salvage with lowest refracture in recent reports.
When to recommend amputation
After 3-4 failed reconstructions, severe shortening, or infection, many families choose amputation for quality-of-life reasons. Modern below-knee prostheses allow excellent function and sports participation; decision timing and counselling are critical.
CONGENITAL PSEUDARTHROSIS OF THE TIBIA
Clinical summary
Key Biology and NF1
- •NF1 mutation in 50-80 percent; drives poor osteoblast function and fibrous hamartoma
- •Hamartoma produces TGF-beta, is hypovascular, and replaces normal bone at pseudarthrosis site
Crawford Classification
- •Type I: anterolateral bow, normal canal - best prognosis, brace
- •Type II: narrowed canal, sclerosis - protect, consider early surgery
- •Type III: cystic lesion - high fracture risk, surgical threshold
- •Type IV: established pseudarthrosis - worst outcome, surgery mandatory
Natural History
- •Anterolateral bowing begins in infancy; mean fracture age 2.5 years if untreated
- •Once fractured, biology changes permanently; refracture greater than 50 percent after union
Surgical Principles
- •Debride hamartoma, stabilise (Ilizarov, rod, plate), address fibula
- •Cross-union or vascular fibula for lowest refracture; protect 6-12 months post-union
Complications and Endpoints
- •Refracture greater than 50 percent, LLD 2-5 cm, ankle valgus, amputation 10-30 percent
- •Amputation is realistic endpoint after multiple failures; modern prosthetics give excellent function